REFERENCES
- Caplan JP, Epstein LA, Quinn DK, Stevens JR, Stern TA. Neuropsychiatric effects of prescription drug abuse. Neuropsychol Rev 2007; 17(3):363–380.
- Substance Abuse and Mental Health Services Administration. Results from the 2007 National Survey on Drug Use and Health: National Findings. Rockville, MD: Office of Applied Studies, NSDUH Series H-34, DHHS Publication No. SMA 08-4343, 2008.
- Jalbert JJ, Quilliam BJ, Lapane KL. A profile of concurrent alcohol and alcohol-interactive prescription drug use in the US population. J Gen Intern Med 2008; 23(9):1318–1323.
- McCabe SE, Cranford JA, Boyd CJ. The relationship between past-year drinking behaviors and nonmedical use of prescription drugs: Prevalence of co-occurrence in a national sample. Drug Alcohol Depend 2006; 84(3):281–288.
- Substance Abuse and Mental Health Services Administration. Drug Abuse Warning Network: The DAWN Report, Benzodiazepine in Drug-Abuse Related Emergency Department Visits: 1995–2002, 2004.
- Krystal JH, Staley J, Mason G, Petrakis IL, Kaufman J, Harris RA, Gelernter J, Lappalainen J. Gamma-aminobutyric acid type A receptors and alcoholism: Intoxication, dependence, vulnerability, and treatment. Arch Gen Psychiatry 2006; 63(9):957–968.
- Arcangeli A, Antonelli M, Mignani V, Sandroni C. Sedation in PACU: The role of benzodiazepines. Curr Drug Targets 2005; 6(7):745–748.
- Rigg KK, Ibanez GE. Motivations for nonmedical prescription drug use: A mixed methods analysis. J Subst Abuse Treat 2010; 39(3):236–247.
- McCabe SE, Boyd CJ, Teter CJ. Subtypes of nonmedical prescription drug misuse. Drug Alcohol Depend 2009; 102(1–3):63–70.
- Teter CJ, McCabe SE, Cranford JA, Boyd CJ, Guthrie SK. Prevalence and motives for illicit drug use of prescription stimulants in an undergraduate student sample. J Am Coll Health 2005; 53(6):253–262.
- McCabe SE, Cranford JA, Boyd CJ, Teter CJ Motives, diversion and routes of administration associated with nonmedical use of prescription opioids. Addict Behav 2007; 32(3):562–575.
- Nattala P, Leung KS, Ben Abdallah A, Cottler LB. Heavy use versus less heavy use of sedatives among nonmedical sedative users: Characteristics and correlates. Addict Behav 2010; 36(1–2):103–109.
- Watters JK, Biernacki P. Targeted sampling: Options for the study of hidden populations. Soc Probl 1989; 36:416–430.
- Leung KS, Ben Abdallah A, Copeland J, Cottler LB. Modifiable risk factors of ecstasy use: Risk perception, current dependence, perceived control, and depression. Addict Behav 2010; 35(3):201–208.
- Shacham E, Cottler LB. Sexual behaviors among club drug users: Prevalence and reliability. Arch Sex Behav 2010; 39(6):1331–1341.
- Cottler LB, Ben Abdallah A, Cummings SM, Barr J, Banks R, Forchheimer R. Injury, pain, and prescription opioid use among former National Football League (NFL) players. Drug Alcohol Depend 2011 [Epub ahead of print].
- Ben Abdallah A, Scheier LM, Inciardi JA, Copeland J, Cottler LB. A psycho-economic model of ecstasy consumption and related consequences: A multi-site study with community samples. Subst Use Misuse 2007; 42(11):1651–1684.
- Del Rio MC, Prada C, Alvarez FJ. Do Spanish patients drink alcohol while undergoing treatment with benzodiazepines? Alcohol 2002; 26(1):31–34.
- Veldhuizen S, Wade TJ, Cairney J. Alcohol consumption among Canadians taking benzodiazepines and related drugs. Pharmacoepidemiol Drug Saf 2009; 18(3):203–210.
- Cox WM, Klinger E. A motivational model for alcohol use. J Abnorm Psychol 1988; 97(2):168–180.
- Peterson PL, Baer JS, Wells E, Ginzler JA, Garrett SB. Short-term effects of a brief motivational intervention to reduce alcohol and drug risk among homeless adolescents. Psychol Addict Behav 2006; 20(3):254–264.
- Miller WR Enhancing Motivation for Change in Substance Abuse Treatment: Treatment Improvement Protocol Series (TIP) 35. Rockville, MD: DHHS Publication No. (SMA) 99-3354, 1999.
- Sethi BB, Trivedi JK, Kumar P, Gulati A, Agarwal AK, Sethi N. Antianxiety effect of cannabis: Involvement of central benzodiazepine receptors. Biol Psychiatry 1986; 21(1):3–10.